Filing Details
- Accession Number:
- 0001127602-13-035791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-30 17:18:30
- Reporting Period:
- 2013-12-27
- Filing Date:
- 2013-12-30
- Accepted Time:
- 2013-12-30 17:18:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532023 | S Julian Gangolli | 2525 Dupont Drive Irvine CA 92612 | Cvp & Pres, North America | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-27 | 15,000 | $40.16 | 23,047 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-27 | 15,000 | $110.17 | 8,047 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-12-27 | 37,500 | $59.13 | 45,547 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-27 | 37,500 | $110.00 | 8,047 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-27 | 15,000 | $0.00 | 15,000 | $40.16 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-27 | 37,500 | $0.00 | 37,500 | $59.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-02-20 | No | 4 | M | Direct | |
| 12,500 | 2020-02-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 220 | Indirect | By ESOP Trust |
| Common Stock | 16,900 | Indirect | By The Gangolli Family Trust |
| Common Stock | 264 | Indirect | By Wife's 401(k) plan |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 9, 2013.
- Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
- Shares allocated to the reporting person's ESOP account as of reporting date.
- Shares held by The Gangolli Family Trust established June 1, 2011, of which the reporting person and his spouse are each trustees.
- The option became exercisable in four equal annual installments beginning February 20, 2010. The remaining outstanding options for this award are reported in this filing.
- The option became exercisable in four equal annual installments beginning February 22, 2011.
Billionaire Hedge Funds
